TEAD4 and coronary artery disorder: Interestingly, a CAD GWAS risk variant disrupts binding of TEAD4 in smooth muscle cells, causing lower expression of p16, which could potentially contribute to the risk identified at this locus (Almontashiri et al., 2015).